Contrast‐enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma
- 24 December 2014
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 94 (3) , 266-273
Abstract
Objective: To determine the ability of contrast‐enhanced magnetic resonance imaging to predict myometrial invasion, cervical invasion, and pelvic lymph node metastasis in endometrial carcinoma and to analyze factors that lead to errors in this identification.Design: A retrospective study.Setting: University general hospital.Population: A total of 167 women diagnosed with endometrial carcinoma.Methods: All patients received a preoperative contrast‐enhanced magnetic resonance imaging scan. Histopathological findings were used as the definitive diagnosis.Main outcome measures: The results were compared with histopathological findings, factors that make accurate assessment of myometrial invasion, cervical invasion, and pelvic lymph node metastasis difficult by contrast‐enhanced magnetic resonance imaging were analyzed.Results: The sensitivity, specificity, diagnostic accuracy, positive predictive values, and negative predictive values of contrast‐enhanced magnetic resonance imaging were 90.9, 91.8, 91.6, 73.2 and 97.6%, respectively, for identifying deep myometrial invasion; 84.2, 96.0, 94.6, 72.7 and 97.9%, respectively, for identifying cervical invasion; and 45.0, 91.2, 85.6, 40.9 and 92.4%, respectively, for identifying pelvic lymph node metastasis. The main causes of error in contrast‐enhanced magnetic resonance imaging were myomas, cornual lesions, deep myometrial invasion, large tumor size, non‐endometrioid tumor type, and lower tumor grade.Conclusion: Contrast‐enhanced magnetic resonance imaging has a high accuracy and a low tendency to produce false‐negative predictive values. Gynecological oncologists should combine the imaging data and clinical information to make therapeutic decisions and avoid diagnostic errors.Keywords
Funding Information
- Natural Science Fund of China (No.81101985)
- Natural Science Fund of Tianjin Municipal Science and Technology Commission, China (No.12JCYBJC17900)
This publication has 18 references indexed in Scilit:
- New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging systemJournal of Surgical Oncology, 2012
- The preoperative assessment of deep myometrial invasion by three‐dimensional ultrasound versus MRI in endometrial carcinomaActa Obstetricia et Gynecologica Scandinavica, 2012
- Does the FIGO 2009 Endometrial Cancer Staging System More Accurately Correlate With Clinical Outcome in Different Histologies?International Journal of Gynecological Cancer, 2012
- Lifestyle Challenges in Endometrial Cancer SurvivorshipObstetrics & Gynecology, 2011
- Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma: Comparison of multi-section dynamic MR imaging using a three dimensional FLASH technique and T2-weighted MR imagingJournal of Medical Imaging and Radiation Oncology, 2010
- Assessment of Myometrial Invasion in Endometrial Cancer by Transvaginal Sonography, Doppler Ultrasonography, Magnetic Resonance Imaging and Frozen SectionInternational Journal of Gynecological Cancer, 2009
- Tolerance of radiofrequency ablation by patients of hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2009
- Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging systemEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and histopathologic evaluationJournal of Obstetrics and Gynaecology, 2007
- MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node MetastasisCancer Research and Treatment, 2007